companies innovating in obesity treatment glp-1 drugs 2025 2025’s Breakthrough Treatments: Top & Innovations Next-Generation GLP-1 Innovation Could Unlock
Description
Accessed September 24, 2021
Jorsal A, Kistorp C, Holmager P et al (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)a multicentre, double-blind, randomised, placebo-controlled trial
studied the effects of semaglutide in ovariectomized rats as a model for postmenopausal osteoporosis
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
